# Protocol for Correlating Enteropathic Severity and Small Intestinal CYP3A4 Activity in Patients With Celiac Disease

> **NCT01338324** · PHASE2,PHASE3 · COMPLETED · sponsor: **All India Institute of Medical Sciences** · enrollment: 41 (actual)

## Conditions studied

- Celiac Disease

## Interventions

- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT01338324
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-06
- **Final completion:** 2011-09
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2011-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01338324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01338324, "Protocol for Correlating Enteropathic Severity and Small Intestinal CYP3A4 Activity in Patients With Celiac Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01338324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*